Financial Statements — FRNM
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Cash & Equivalents | 0.44 | 0.57 | 1.18 | 1.34 | 1.19 | 1.21 | 1.29 |
| Total Current Assets | 0.74 | 0.65 | 1.26 | 1.47 | 1.34 | 1.37 | 1.43 |
| Total Non-current Assets* | 85.09 | 92.68 | 90.94 | 89.94 | 89.29 | 87.64 | 86.46 |
| Total Assets | 85.83 | 93.33 | 92.20 | 91.40 | 90.63 | 89.01 | 87.89 |
| Total Current Liabilities | 3.63 | 2.86 | 0.93 | 0.28 | 0.27 | 0.16 | 0.03 |
| Total Non-current Liabilities* | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 |
| Total Liabilities | 7.08 | 6.31 | 4.38 | 3.73 | 3.72 | 3.61 | 3.48 |
| Retained Earnings | (6.30) | (5.66) | (3.12) | (2.27) | (2.37) | (1.94) | (1.74) |
| Total Stockholder Equity | (6.30) | (5.66) | (3.12) | (2.27) | (2.37) | (1.94) | (1.74) |
* Derived from reported values
Income Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Selling, General & Admin | 0.94 | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 0.86 | -- | 0.86 | 0.19 | 0.26 | 0.20 | 0.11 |
| Operating Income | (0.94) | (0.86) | (1.68) | (0.86) | (0.19) | (0.26) | (0.20) | (0.11) |
| Net Income | (0.11) | (0.05) | (0.74) | 0.14 | 0.75 | 0.68 | 0.98 | 0.09 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Operating Cash Flow | (0.13) | (0.30) | (0.31) | (0.17) | (0.15) | (0.24) | (0.27) | (0.20) |
| Investing Cash Flow | 8.16 | 0.00 | 0.00 | 0.00 | 0.30 | 0.30 | (86.25) | (86.25) |
| Financing Cash Flow | (8.16) | -- | 0.00 | 0.00 | 0.00 | -- | 87.73 | 87.73 |
